Chairperson: Evidence Communication

Haemato-oncological Cancers

Improving design of clinical trials

Multiple myeloma (A cancer arising from plasma cells)

Multiple myeloma (A cancer arising from plasma cells)

ESMO 2023: Highlights and analysis

Cabozantinib shows clinically meaningful improvement in advanced neuroendocrine tumours

Tisotumab vedotin shows clinically meaningful OS improvement versus chemo for metastatic cervical cancer

CAR-T therapy and impact to cancer patient outcomes and experience of treatment

Pembrolizumab plus chemoradiotherapy shows clinically meaningful improvement in PFS for locally advanced cervical cancer

Hope vs Hype of evidence interpretation

Haemato-oncological Cancers